Search

Your search keyword '"Cohen, Jordana"' showing total 327 results

Search Constraints

Start Over You searched for: Author "Cohen, Jordana" Remove constraint Author: "Cohen, Jordana" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
327 results on '"Cohen, Jordana"'

Search Results

1. Proteome-Wide Genetic Investigation of Large Artery Stiffness

3. Lowering Nighttime Blood Pressure With Bedtime Dosing of Antihypertensive Medications: Controversies in Hypertension - Con Side of the Argument

4. Response to Lowering Nighttime Blood Pressure with Bedtime Dosing of Antihypertensive Medications: Controversies in Hypertension - Pro Side of the Argument.

5. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications

6. Treating Home Versus Predialysis Blood Pressure Among In-Center Hemodialysis Patients: A Pilot Randomized Trial.

10. Emergency Department/Urgent Care as Usual Source of Care and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort Study

11. Prediction of Incident Heart Failure in CKD: The CRIC Study

13. Proteomic Correlates and Prognostic Significance of Kidney Injury in Heart Failure With Preserved Ejection Fraction.

15. Proteomic Associations of Adverse Outcomes in Human Heart Failure

24. Cardiac Biomarkers and Risk of Mortality in CKD (the CRIC Study)

25. Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone

26. Association Between Self‐Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial)

30. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications

34. New Users of Angiotensin II Receptor Blocker–Versus Angiotensin‐Converting Enzyme Inhibitor–Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD‐BP and SPRINT

39. Clinical and Proteomic Correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in Human Heart Failure

42. Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit

43. Proteomic cardiovascular risk assessment in chronic kidney disease

44. PROTEOMIC CORRELATES OF PLASMA POTASSIUM (K+) IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)

45. URINARY PROTEINS LEVELS ASSOCIATED WITH OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION

46. PROTEOMIC ASSOCIATIONS OF N-TERMINAL (NT)-PRO HORMONE BNP (NT-PROBNP) IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)

47. EFFECT OF SPIRONOLACTONE ON THE PLASMA PROTEOME IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF): IMPACT OF BASELINE N-TERMINAL (NT)-PRO B-TYPE NATRIURETIC PEPTIDE (BNP) LEVELS

48. Prognostic utility of rhythmic components in 24-hour ambulatory blood pressure monitoring for the risk stratification of chronic kidney disease patients with cardiovascular co-morbidity

49. Socioeconomic characteristics of those with peripheral artery disease in the chronic renal insufficiency cohort

Catalog

Books, media, physical & digital resources